Примери за използване на Interferon beta на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Subcutaneous and intramuscular administrations of Rebif produce equivalent exposure to interferon beta.
The following side effects were reported for interferon beta(frequency not known).
Interferon alpha, interferon beta, and interferon gamma have overlapping yet distinct biologic activities.
Hypothyroidism and hyperthyroidism have been observed with the use of interferon beta products.
Cases of pulmonary arterial hypertension(PAH) have been reported with interferon beta products.
However, the effects of interferon beta that are dependent on glycosylation are not fully defined.
Natural interferon beta and AVONEX(interferon beta-1a)
A few rounds of cross-breeding the male chicks resulted in chickens that inherited the genes with interferon beta.
Caution should be used and close monitoring considered when administering Interferon beta to patients with severe renal failure.
If you are allergic(hypersensitive) to interferon beta, or any other of the other ingredients in.
have been reported with the use of subcutaneous interferon beta.
As rodents do not react to human interferon beta, repeated dose studies were carried out with rhesus monkeys.
may occur after several years of treatment with interferon beta.
information from the published literature on other medicines containing interferon beta.
may be worsened by interferon beta treatment.1.
Patients with a history of hypersensitivity to natural or recombinant interferon beta or to any excipients listed in section 6.1.
Serious hypersensitivity reactions including cases of anaphylaxis have been reported as a rare complication of treatment with interferon beta, including Plegridy.
Rebif is a highly purified soluble protein that is similar to the natural interferon beta that is produced in the human body.
The protein in Avonex is made up of exactly the same ingredients as interferon beta that is found in the human body.
clinical experience with interferon beta, the potential for carcinogenicity is expected to be low.